Literature DB >> 31582021

Hormone Therapy for Transgender Adults.

Asa Radix1.   

Abstract

Transgender people have a gender identity that differs from their sex assigned at birth. For many transgender individuals accessing gender affirming hormone therapy (GAHT) is an important and medically necessary step in their gender transition. Both feminizing and masculinizing regimens are safe when used within established hormone protocols and are associated with significant improvements in mental health outcomes, including reduction in depression, anxiety and gender dysphoria. Clinicians should be aware of the current best practice guidelines for initiating and maintaining patients on GAHT.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical guidelines; Cross-gender hormones; Endocrine treatment; Gender-affirming care; Hormones; Transfeminine; Transgender; Transmasculine

Mesh:

Substances:

Year:  2019        PMID: 31582021     DOI: 10.1016/j.ucl.2019.07.001

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  2 in total

Review 1.  Epilepsy Care in Transgender Patients.

Authors:  Genna Waldman; Rachael Benson
Journal:  Curr Neurol Neurosci Rep       Date:  2022-06-06       Impact factor: 6.030

2.  Macular Abnormalities Associated With 5α-Reductase Inhibitor.

Authors:  Yong Kyun Shin; Geun Woo Lee; Se Woong Kang; Sang Jin Kim; A Young Kim
Journal:  JAMA Ophthalmol       Date:  2020-07-01       Impact factor: 7.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.